Munafa Stock Market Course + Intraday & FNO calls 
Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for USA stock ARWR Arrowhead Pharmaceuticals. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 64.76 and Closed at: 62.35, which is -2.95% of previous session's close. It moved within a range of 62.22 and 64.76
The session was a Bearish session with an average volume of 2249400, which is 33.87% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Dead cross was found 2 days back on long term averages
Support for tomorrow is 61.02 and resistance for tomorrow is 63.56
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 61.46, 60.57 resistance for tomorrow's hourly charts is 64, 65.65
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 65.93 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 70.64 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 80.35 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 79.16 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 72.71 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 70.64 and 200 DMA is at 72.71, while 50 DMA and 100 DMA are at 80.35 and 79.16 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 70.64 and 20 EMA is at 70.08
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 62.35 | 70.64 | 70.08 |
| 02 Fri Oct | 64.19 | 71.84 | 70.89 |
| 01 Thu Oct | 64.79 | 72.95 | 71.59 |
| 30 Wed Sep | 65.45 | 73.98 | 72.3 |
| 29 Tue Sep | 66.25 | 74.85 | 73.02 |
| 28 Mon Sep | 65.46 | 75.65 | 73.73 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 80.35 and 50 EMA is at 75.88
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 62.35 | 80.35 | 75.88 |
| 02 Fri Oct | 64.19 | 80.82 | 76.43 |
| 01 Thu Oct | 64.79 | 81.24 | 76.93 |
| 30 Wed Sep | 65.45 | 81.68 | 77.43 |
| 29 Tue Sep | 66.25 | 82.15 | 77.92 |
| 28 Mon Sep | 65.46 | 82.31 | 78.4 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 79.16 and 100 EMA is at 76.2
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 62.35 | 79.16 | 76.2 |
| 02 Fri Oct | 64.19 | 79.32 | 76.48 |
| 01 Thu Oct | 64.79 | 79.46 | 76.73 |
| 30 Wed Sep | 65.45 | 79.59 | 76.97 |
| 29 Tue Sep | 66.25 | 79.67 | 77.2 |
| 28 Mon Sep | 65.46 | 79.78 | 77.42 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 72.71 and 200 EMA is at 68.89
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 62.35 | 72.71 | 68.89 |
| 02 Fri Oct | 64.19 | 72.73 | 68.96 |
| 01 Thu Oct | 64.79 | 72.73 | 69.01 |
| 30 Wed Sep | 65.45 | 72.75 | 69.05 |
| 29 Tue Sep | 66.25 | 72.77 | 69.09 |
| 28 Mon Sep | 65.46 | 72.79 | 69.12 |
Zoetis Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Zoetis Inc, about 23.82% more returns!
Msa Safety has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Msa Safety, about 23.78% more returns!
Inspire Medical has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Inspire Medical, about 40.6% more returns!
Humana Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Humana Inc, about 26.98% more returns!
Glaukos Corporation has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Glaukos Corporation, about 15.37% more returns!
Elanco Animal has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Elanco Animal, about 20.65% more returns!
Boston Scientific has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Boston Scientific, about 21.07% more returns!
Bristol Myers has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Bristol Myers, about 17.65% more returns!
Therapeuticsmd Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 20.67% more returns!
Si Bone has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 33.13% more returns!
Rhythm Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 17.56% more returns!
Proqr Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Proqr Therapeutics, about 8.2% more returns!
Ironwood Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 14.27% more returns!
Cytokinetics Incorporated has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 9.95% more returns!
Cue Biopharma has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Cue Biopharma, about 7.94% more returns!
Addus Homecare has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Addus Homecare, about 21.43% more returns!
Adma Biologics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Adma Biologics, about 32.71% more returns!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term and the sell signal is strong.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arrowhead Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.34 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
